New study aims to ease suffering after stem cell transplants in vulnerable patients

NCT ID NCT03870750

First seen Jan 12, 2026 · Last updated Apr 30, 2026 · Updated 15 times

Summary

This study tested two approaches—supportive and palliative care (focusing on symptom relief) and clinical management of other health problems (like heart or lung disease)—to see if they could improve quality of life and survival after a donor stem cell transplant. It included 458 older, weak, or frail patients with blood diseases. The goal was to find the best way to reduce suffering and improve outcomes after transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

    Houston, Texas, 77030, United States

  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

    Cleveland, Ohio, 44195, United States

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Northwell Health Cancer Institute

    New Hyde Park, New York, 11042, United States

  • Oregon Health and Science University

    Portland, Oregon, 97239, United States

  • Stanford Cancer Institute Palo Alto

    Palo Alto, California, 94304, United States

  • University of California San Francisco

    San Francisco, California, 94143, United States

  • University of Minnesota/Masonic Cancer Center

    Minneapolis, Minnesota, 55455, United States

  • Vanderbilt University

    Nashville, Tennessee, 37232, United States

  • Wayne State University/Karmanos Cancer Institute

    Detroit, Michigan, 48201, United States

Conditions

Explore the condition pages connected to this study.